The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration

• Michele FusaroliUniversity of Bologna
• Francesco SalvoUniversité de Bordeaux
• Bernard BégaudUniversité de Bordeaux
• Thamir M. AlshammariAlmaarefa University
• Andrew BateLondon School of Hygiene & Tropical Medicine
• Vera BattiniUniversity of Milan
• Andreas BruecknerNovartis (Switzerland)
• Gianmario CandoreBayer (Germany)
• Carla CarnovaleUniversity of Milan
• Salvatore CrisafulliUniversity of Verona
• Paola Maria CutroneoUniversity of Messina
• Charles DolladilleNormandie Université
• Milou‐Daniel DriciUniversité Côte d'Azur
• Jean‐Luc FaillieInserm
• Adam GoldmanTel Aviv University
• Manfred HaubenPfizer (United States)
• María Teresa HerdeiroUniversity of Aveiro
• Olivia Mahaux
• Katrin ManlikBayer (Germany)
• François MontastrucCentre Hospitalier Universitaire de Toulouse
• Yoshihiro NoguchiGifu Pharmaceutical University
• G. Niklas NorénUppsala Monitoring Centre
• Roberta NosedaEnte Ospedaliero Cantonale
• Igho OnakpoyaUniversity of Oxford
• Antoine ParienteUniversité de Bordeaux
• Elisabetta PoluzziUniversity of Bologna
• Myriam SalemHealth Canada
• Daniele SartoriUppsala Monitoring Centre
• Nhung TH TrinhUniversity of Oslo
• Marco TuccoriUniversity of Pisa
• Florence P. A. M. van HunselUniversity of Groningen
• Eugène van PuijenbroekUniversity of Groningen
• Emanuel RaschiUniversity of Bologna
• Charles KhouriInserm